CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on developing a drug discovery platform using patient-derived organoids and machine learning to identify treatments targeting stem cell signaling pathways in colorectal cancer. It aims to improve therapeutic options for advanced-stage cancer patients by validating new approaches to combat treatment…
Colorectal cancer (CRC) is one of the most frequent cancers with a high burden on society.
In Europe alone, more than 340,000 people are diagnosed with colorectal cancer each year.
While treatment options of CRC have expanded over the last decades, the survival rates of patients suffering from advanced-stage cancers remain poor.
Stemness of neoplastic cells has been proposed as a major factor in treatment resistance and high relapse rates, however, drugs targeting stem cell signaling pathways in…
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Heidelberg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
